570 filings
Page 4 of 29
CORRESP
sljif2 cp
18 Oct 23
Correspondence with SEC
12:00am
SC 13D/A
ieyrn023a2lcas9d2e
10 Oct 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
4:42pm
4
1uhkswqh
10 Oct 23
Neoleukin Therapeutics / JULIAN BAKER ownership change
4:22pm
SEC STAFF LETTER
pgzd3xx8qx3wca8ha3
10 Oct 23
SEC staff letter
12:00am
UPLOAD
95d wuar6eaf
10 Oct 23
Letter from SEC
12:00am
425
dtb8w7k54h furn2o
5 Oct 23
Business combination disclosure
12:50pm
S-4/A
pag2x6s0y e190
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
CORRESP
wnbpxl8wskadpr9
28 Sep 23
Correspondence with SEC
12:00am
8-K
c8uw940lgm4ptqqyqiz
22 Sep 23
Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split
8:03am
UPLOAD
7x5sj9m50h9 pb
18 Sep 23
Letter from SEC
12:00am
S-4
dlioha48711o
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
SC 13D/A
fn4 wfbcqv86kov265gl
17 Aug 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
5:12pm
4
aobxylowibpn9qabn
17 Aug 23
Neoleukin Therapeutics / JULIAN BAKER ownership change
5:08pm
4
tqzh2sqxx xkq
14 Aug 23
Neoleukin Therapeutics / Sean Michael Smith ownership change
4:06pm
SC 13D
lzwu1e
27 Jul 23
Neoleukin Therapeutics / Redmile ownership change
5:15pm
SC 13D/A
2xbkm2
19 Jul 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
5:28pm
425
qvew8nd
18 Jul 23
Business combination disclosure
4:02pm
425
mn9xzpjgg4
18 Jul 23
Business combination disclosure
8:37am